Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
ALNY Key Statistics
Stock Snapshot
As of today, Alnylam Pharmaceuticals(ALNY) shares are valued at $451.23. The company's market cap stands at 59.63B, with a P/E ratio of 1877.00.
As of 2025-11-30, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $444.43 and $455.76. The current price stands at $451.23, placing the stock +1.5% above today's low and -1.0% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 559.32K, compared to an average daily volume of 981.05K.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
ALNY News
Below is Validea's guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY). Of the 22 guru strategies we follow, ALNY rates highest using our Twin Mome...
Earlier this quarter, Carillon Tower Advisers highlighted Alnylam Pharmaceuticals after the company's launch of vutrisiran for transthyretin amyloidosis surpass...
Below is Validea's guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY). Of the 22 guru strategies we follow, ALNY rates highest using our Quantitat...
Analyst ratings
68%
of 31 ratingsMore ALNY News
Wondering if Alnylam Pharmaceuticals stock offers real value, or if recent momentum has left the price running ahead of its fundamentals? You're definitely not...